Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune-mediated thrombotic thrombocytopenic purpura in the United States

CONCLUSIONS: Despite treatment with TPE and immunosuppressants, patients with iTTP have high risk of morbidity and mortality, demonstrating the need for more effective therapies.PMID:36176310 | PMC:PMC9481884 | DOI:10.1002/rth2.12802

Source: Thrombosis and Haemostasis - September 30, 2022 Category: Hematology Authors: Ayoade Adeyemi Francesca Razakariasa Alexandra Chiorean Rui de Passos Sousa Source Type: research